Navigation Links
First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
Date:5/15/2008

Excellent results obtained with a newly cleared device to identify the lipid core (fatty) coronary plaques of interest that are associated with

complications of coronary stenting

BURLINGTON, Mass., May 15 /PRNewswire/ -- InfraReDx, Inc. today announced that physicians at Beaumont Hospital in Royal Oak, Mich., have successfully used its LipiScan(TM) Coronary Imaging System in a patient undergoing a cardiac catheterization. This is the first patient in the world in whom it has been possible to assess the chemical composition of coronary artery plaques and utilize such information to assist in the management of coronary artery disease.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080515/NETH104 )

Dr. Daniel Schultz, Director of the FDA Center for Devices and Radiological Health, has stated, "This is the first device that can help assess the chemical make-up of coronary artery plaques and help physicians identify those plaques with lipid cores, which may be of particular concern."

Physicians at Beaumont Hospital performed the procedure on May 8, 2008 in a 70-year old male patient. The LipiScan System revealed the presence of a lipid core containing plaque not detectable by conventional diagnostic measures. This fatty plaque was located near a narrowing that required a coronary stent for the usual reasons. Because of the presence of this plaque, the physicians selected a stent that was 50 percent longer than the one that would have been used to cover the narrowing only. This longer stent covered the lipid core containing plaque and avoided placing the end of a shorter stent in the fatty plaque. Termination of a stent in a fatty plaque has been associated with clotting of the stent years after placement.

"If doctors can identify these fatty plaques, we can recommend better treatment options to patients," says Simon Dixon, M.D.
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...TOWN, N.J., Nov. 6 Watso...pecialty pharmaceutical company, announced today t...utive officer, will provide an overview and update...th Annual Healthcare Conference on Wednesday, Nove..., This presentation will be webcast live and ca...
(Date:11/6/2009)...TA, Fla., Nov. 6 Roper ...at it has signed a definitive agreement to acquire... medical devices. The Verathon Board of Directors...ubject to customary regulatory approvals and closi...e parties expect the closing to be completed in ea...
(Date:11/6/2009)...GTON, Nov. 6 America,s ...working group of mid-market and smaller innovator ... about H.R. 3962, the "Affordable Health Care for ...hursday. These smaller companies fear that the cu...62 will hinder their efforts to bring new medicine...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Consecos Four Major Offices Wrap Up Record Breaking United Way Campaign 59579 1Consecos Four Major Offices Wrap Up Record Breaking United Way Campaign 59579 2BioMed Realty Trust to Report 2009 Third Quarter Results 59577 1BioMed Realty Trust to Report 2009 Third Quarter Results 59577 2ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26 5520 1
(Date:11/8/2009)... Tonight the House of Re...r America Act, landmark health reform legislation ...ity, affordable, stable and secure health care cov...of the insurance industry,s worst practices, would...he deficit by $104 billion over ten years. Groups ...
(Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be availab...ility. , Toronto, ON (PR... and CEO of Therapure Biopharma Inc. today announc...cial scale pharmaceutical grade freeze dryer and e...philization) available for contract manufacturing ...
(Date:11/8/2009)... Today, the House of Rep...lkemper, Smith, Ellsworth and Lipinski amendment t...R. 3962). The amendment maintains the current poli...for benefits packages that include abortion. It cl...ffordability credits and those who do not, can wit...
(Date:11/8/2009)... USAction this evening h...erica Act, which will make health care more afford...ntable and increase access to health care for mill...Teddy Roosevelt, FDR and Harry Truman would be pro..."Today,s vote ranks among our country,s proudest a...
(Date:11/8/2009)... The following was relea...scue Insurrecta Nex. ,, Mr. Terry and his asso...to keep child-killing by abortion out of any healt...his is a great first step to victory -- a touchdow...hting ahead of us. Our rejoicing must be tempered ...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
...th-whitening products at the drugstore or dentist’...esearch suggests there's a good chance they’re eff...aid Dr. Hana Hasson, clinical associate professor ...n't consider the studies in favor of the products ...
...tos) has been linked to health benefits as well as...examined 22 studies of the drug involving 6,200 ty...nd Richter said ‘Our results showed that published...tient-oriented outcomes like mortality, morbidity,...
According to a recent study, patients with Irritable Bowl Syndrome (IBS) showed greater improvements and less bloating on taking the antibiotic, rifaximin. //It is for the first time that a randomize
...ow intense struggle among the human immune system'... harm and take on a more virulent form, developing...hich uses a computer model of simultaneous virus a...n Physical Review Letters, is available online at ...
...rity of obsessive compulsive disorder in children ...orm of treatment helps relieve the overall distres...s can cause in young people’s lives. Further,...chard O'Kearney and colleagues. "When CBT is...
...on the health benefits versus risks of an oral med...e United States, Canada, Europe and Asia. // ...e United States by Takeda Pharmaceuticals North Am...glitazone treatment in people with type 2 diabetes...
Other Medicine News:Health News:Tooth-Whitening Products Work for Brightening Smiles in Short Term 2Health News:Tooth-Whitening Products Work for Brightening Smiles in Short Term 3Health News:Diabetes Drug Benefits vs. Risks 2Health News:HIV Takes Advantage of Rivalry among T cells 2Health News:HIV Takes Advantage of Rivalry among T cells 3Health News:Cognitive Behavioral Therapy Helps Children with Obsessive Compulsive Disorder 2Health News:Cognitive Behavioral Therapy Helps Children with Obsessive Compulsive Disorder 3Health News:Widely Prescribed Diabetes Drug Falls Short of Promise, Says New Review 2Health News:Widely Prescribed Diabetes Drug Falls Short of Promise, Says New Review 3
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: